Home › Burkitt Lymphoma › California › Baldwin Park

Pag-aaral pangklinika para sa Burkitt Lymphoma sa Baldwin Park, CA

9 pag-aaral para sa Burkitt Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Baldwin Park (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Nagre-recruitPhase 2

City of Hope Comprehensive Cancer Center, Duarte · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT03739814

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Nagre-recruitPhase 3

City of Hope Comprehensive Cancer Center, Duarte · 4 mi ang layo

365 Days – 25 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03959085

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Nagre-recruitPhase 1/2

Research Site, Duarte · 4 mi ang layo

Edad 12 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT06137118

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

City of Hope, Duarte · 4 mi ang layo

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia

Nagre-recruitPhase 1

City of Hope Medical Center, Duarte · 4 mi ang layo

Edad 12 hanggang 55 · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT07133997

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

Nagre-recruitPhase 1/2

Research Site, Duarte · 4 mi ang layo

Edad 12 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT07109219

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Nagre-recruitPhase 2

City of Hope Medical Center, Duarte · 4 mi ang layo

Edad 18 hanggang 54 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06918431

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Nagre-recruitPhase 1

City of Hope, Duarte · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2025 · NCT04260022

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Nagre-recruitPhase 2

City of Hope, Duarte · 4 mi ang layo

Edad 1 hanggang 25 · Lahat ng kasarian · Na-update May 4, 2025 · NCT03509961

Pag-aaral para sa Burkitt Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Baldwin Park

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.